In vitro production and inhibition of aortic vasoconstriction by mercuric, cadmium, and other metal ions.
D000804:Angiotensin II / Q000494:pharmacology; D000818:Animals; D001013:Aorta, Thoracic / Q000187:drug effects*; D002104:Cadmium / Q000494:pharmacology*; D003486:Cyanides / Q000494:pharmacology; D004492:Edetic Acid / Q000494:pharmacology; D004837:Epinephrine / Q000494:pharmacology; D005033:Ethylmaleimide / Q000494:pharmacology; D005260:Female; D006830:Hydralazine / Q000494:pharmacology; D066298:In Vitro Techniques; D007477:Ions / Q000494:pharmacology*; D008628:Mercury / Q000494:pharmacology*; D008670:Metals / Q000494:pharmacology; D009119:Muscle Contraction / Q000187:drug effects*; D010646:Phentolamine / Q000494:pharmacology; D011817:Rabbits; D013438:Sulfhydryl Compounds / Q000378:metabolism; D014666:Vasomotor System / Q000187:drug effects*
D003486:Cyanides; D007477:Ions; D008670:Metals; D013438:Sulfhydryl Compounds; D002104:Cadmium; D000804:Angiotensin II; D006830:Hydralazine; D004492:Edetic Acid; D008628:Mercury; D005033:Ethylmaleimide; D004837:Epinephrine; D010646:Phentolamine